Press Release | October 14, 2020
ImCheck Announces Four ICT01 Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting
Read More
Press Release | October 9, 2020
Geeta Vemuri named Top 100 Powerful Women of 2020 by Entrepreneur
Read More
News | October 1, 2020
Skyhawk Therapeutics Named Top 11 Biotech Startup 2020 by Endpoints News
Read More
Press Release | September 17, 2020
Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
Read More
Press Release | September 10, 2020
ImCheck Achieves Initial Positive Independent Safety Review and Initiates Next Stage of Phase I/IIa EVICTION Trial for ICT01. Company Receives FDA Approval for US IND
Read More
News | August 26, 2020
Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Read More
News | August 17, 2020
BMS Licenses IL-12 from Dragonfly in $475 Million Upfront Deal
Read More
News | July 29, 2020
Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital
Read More
Press Release | July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Read More
News | July 23, 2020
Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri
Read More
Press Release | July 16, 2020
Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner
Read More
Press Release | July 15, 2020
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
Read More
Press Release | July 9, 2020
ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer
Read More
Press Release | July 9, 2020
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
Read More
Press Release | July 8, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
Read More
News | July 6, 2020
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Read More
Press Release | July 6, 2020
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
Read More
Press Release | June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Read More
Press Release | June 18, 2020
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Read More
News | June 3, 2020
Biotech Pliant Therapeutics pulls off $144M IPO to advance fibrosis pipeline
Read More
